Halawa Alaa bought NMRA
May 27, 2026 · Form 4 insider transaction
Halawa Alaa bought 80,000 shares of Neumora Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,000
Price
$0.00
Total value
N/A
InsiderHalawa Alaa
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 27, 2026
Filing dateMay 29, 2026
Shares owned after80,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option vest on the earlier of (i) the one year anniversary of May 27, 2026 or (ii) immediately prior to the next Annual Meeting following May 27, 2026.